Nektar Therapeutics
(NASDAQ : NKTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.16%152.840.7%$1192.90m
PFEPfizer Inc. -0.96%34.060.9%$1173.78m
MRKMerck & Co., Inc. -1.52%72.190.7%$851.36m
BMYBristol-Myers Squibb Co. -2.61%59.171.0%$791.01m
ABBVAbbVie, Inc. -1.06%105.581.9%$738.20m
LLYEli Lilly & Co. -0.81%200.361.1%$642.04m
AZNAstraZeneca Plc -0.56%46.901.2%$494.43m
GSKGlaxoSmithKline Plc -0.39%34.110.2%$282.58m
NVSNovartis AG -1.18%83.190.2%$165.16m
SNYSanofi 0.51%45.690.2%$156.93m
VTRSViatris, Inc. -3.17%13.440.0%$147.01m
VERUVeru, Inc. -8.75%12.000.0%$99.82m
NVONovo Nordisk A/S -3.40%69.030.1%$84.24m
KALVKalVista Pharmaceuticals, Inc. -1.31%31.770.4%$82.65m
RPRXRoyalty Pharma Plc -3.19%42.180.2%$80.23m

Company Profile

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.